Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2007 Mar;66(3):422-3.
doi: 10.1136/ard.2006.060541. Epub 2006 Dec 19.

Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra

Pedro J Ruiz, Eliezer Masliah, Taylor A Doherty, Ai Quach, Gary S Firestein
Case Reports

Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra

Pedro J Ruiz et al. Ann Rheum Dis. 2007 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. Dinarello C A. Interleukin‐18. Methods 199919121–132. - PubMed
    1. Panas D, Khadour F H, Szabo C, Schulz R. Proinflammatory cytokines depress cardiac efficiency by a nitric oxide‐dependent mechanism. Am J Physiol 1998275(Pt 2)H1016–H1023. - PubMed
    1. von Haehling S, Jankowska E A, Anker S D. Tumour necrosis factor‐alpha and the failing heart—pathophysiology and therapeutic implications. Basic Res Cardiol 20049918–28. - PubMed
    1. Anker S D, Coats A J. How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. Int J Cardiol 200286123–130. - PubMed
    1. Chung E S, Packer M, Lo K H, Fasanmade A A, Willerson J T. Randomized, double‐blind, placebo‐controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor‐alpha, in patients with moderate‐to‐severe heart failure: results of the anti‐TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation 20031073133–3140. - PubMed

MeSH terms

Substances